Unibest

Pharmaceutical intermediates

Fostamatinib disodium hexahydrate Intermediates

1 pharmaceutical intermediate for Fostamatinib disodium hexahydrate. Indication: Idiopathic thrombocytopenic purpura; Thrombocytopenia.

提交项目All intermediates

About Fostamatinib disodium hexahydrate

Originator
Rigel Pharmaceuticals Inc
Indication
Idiopathic thrombocytopenic purpura; Thrombocytopenia
Approved Date
04/17/2018
DS/DP
01/19/2026

Available intermediates

1 intermediate currently listed for Fostamatinib disodium hexahydrate. Request specifications, documentation or a quotation for any item below.

Fostamatinib disodium hexahydrate intermediates
Product NameCAS No.Molecular FormulaPhysical Properties
6-Amino-2,2-dimethyl-2H-pyrido[3,2-B][1,4]oxazin-3(4H)-one1002726-62-6//

Other programs under F

FebuxostatFexuprazan HClFezolinetantFilgotinib MaleateFinerenoneFluralanerFruquintinibFutibatinib

Building toward Fostamatinib disodium hexahydrate?

Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.

提交项目 联系团队

我们能如何帮助您？

获取最新活动与法规动态洞察

直接发送到您的邮箱

在此获取行业洞察与 Unibest 动态

联系我们 →